For: | Han YL, Chen L, Qin R, Wang GQ, Lin XH, Dai GH. Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer. World J Gastroenterol 2019; 25(15): 1828-1839 [PMID: 31057297 DOI: 10.3748/wjg.v25.i15.1828] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i15/1828.htm |
Number | Citing Articles |
1 |
Francisco Arvelo, Felipe Sojo. Transición epitelio – mesenquima y cáncer.. Investigación Clínica 2023; 64(3): 379 doi: 10.54817/IC.v64n3a10
|
2 |
Wei Wang, Xiangjun Wang, Feng Yao, Chao Huang. Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer. International Journal of Molecular Sciences 2022; 23(20): 12270 doi: 10.3390/ijms232012270
|
3 |
Keiichiro Nishihara, Keisuke Hori, Takaaki Saito, Toshihiko Omori, Hironori Sunakawa, Tatsunori Minamide, Masayuki Suyama, Yoichi Yamamoto, Yusuke Yoda, Kensuke Shinmura, Hiroaki Ikematsu, Tomonori Yano, Qinghui Zhang. A study of evaluating specific tissue oxygen saturation values of gastrointestinal tumors by removing adherent substances in oxygen saturation imaging. PLOS ONE 2021; 16(1): e0243165 doi: 10.1371/journal.pone.0243165
|
4 |
Su-Hua Li, Yan Li, Meng-Jun Zhang, Qi An, Jia-Nan Tao, Xue-Hong Wang. Interaction Between Hypoxia-Inducible Factor 1-alpha Gene Polymorphism and Helicobacter pylori Infection on Gastric Cancer in a Chinese Tibetan Population. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10776-8
|
5 |
Jessica L. Chitty, Yordanos F.I. Setargew, Thomas R. Cox. Targeting the lysyl oxidases in tumour desmoplasia. Biochemical Society Transactions 2019; 47(6): 1661 doi: 10.1042/BST20190098
|
6 |
Xiaoling Zhu, Jianfang Wang, Xueying Jin, Yiyi Chen, Liang Hu, Jianguo Zhao. Construction and evaluation of a prognostic risk assessment model of gastric cancer by using hypoxia features. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2022; 825: 111795 doi: 10.1016/j.mrfmmm.2022.111795
|
7 |
Aitao Nai, Huihui Zeng, Qiong Wu, Zirui He, Shuwen Zeng, Shoaib Bashir, Feng Ma, Jie He, Wei Wan, Meng Xu. lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.760470
|
8 |
Yordanos F.I. Setargew, Kaitlin Wyllie, Rhiannon D. Grant, Jessica L. Chitty, Thomas R. Cox. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours. Cancers 2021; 13(3): 491 doi: 10.3390/cancers13030491
|
9 |
Nan Yang, Dan-Feng Cao, Xi-Xi Yin, Hong-Hao Zhou, Xiao-Yuan Mao. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases. Biomedicine & Pharmacotherapy 2020; 131: 110791 doi: 10.1016/j.biopha.2020.110791
|
10 |
Donghan Xu, Yehao Luo, Peng Wang, Jiaxin Li, Linrui Ma, Jie Huang, Hao Zhang, Xiaoman Yang, Liqi Li, Yuhong Zheng, Gang Fang, Peiyu Yan. Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1148131
|
11 |
Guangqing Feng, Zewen Chu, Haibo Wang, Yanqing Liu, Fangshi Zhu. Celastrus orbiculatus Extract Inhibits the Invasion and Migration of Human Gastric
Cancer Cells in the Hypoxia Microenvironment. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(18): 3125 doi: 10.2174/1871520622666220421092831
|
12 |
Cynthia Clemente-González, Amancio Carnero. Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation. Cancers 2022; 14(23): 5930 doi: 10.3390/cancers14235930
|
13 |
泽杰 任. Prognostic Impact of Patients with Gastric Cancer Lymph Node Stage. Advances in Clinical Medicine 2024; 14(09): 849 doi: 10.12677/acm.2024.1492538
|
14 |
Zhi-Fu Li, Dong-Dong Meng, Yong-Yi Liu, Fang-Gang Bi, Ke Tian, Jian-Zhong Xu, Jian-Guang Sun, Chen-Xi Gu, Yu Li. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9. Chemico-Biological Interactions 2022; 351: 109759 doi: 10.1016/j.cbi.2021.109759
|
15 |
Sara Tutunchi, Saeedeh Akhavan, Ahmad Bereimipour, Sayyed Mohammad Hossein Ghaderian, Cristina Magi-Galluzzi. Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/5571413
|
16 |
Zirui Jia, Jiacheng Gao, Yuhang Wang, Tingting Zhou, Xiangwen Zhang, Guo Zu. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21402-1
|
17 |
Miaomiao Ye, Yizuo Song, Shuya Pan, Man Chu, Zhi-Wei Wang, Xueqiong Zhu. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy. Pharmacology & Therapeutics 2020; 215: 107633 doi: 10.1016/j.pharmthera.2020.107633
|
18 |
Tsung-Cheng Lin, Cheng-Han Yang, Li-Hsin Cheng, Wen-Tsan Chang, Yuh-Rong Lin, Hung-Chi Cheng. Fibronectin in Cancer: Friend or Foe. Cells 2019; 9(1): 27 doi: 10.3390/cells9010027
|
19 |
Seungyoon Nam, Yeeun Lee. HIF1A protein expression is correlated with clinical features in gastric cancer: an updated systematic review and meta-analysis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-63019-6
|